Flow-mediated dilation in patients with coronary artery disease is enhanced by high dose atorvastatin compared to combined low dose atorvastatin and ezetimibe: results of the CEZAR study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples